This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, Gadner H, Lion T . Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection Leukemia 1999 13: 2060–2069
Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T . Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT Bone Marrow Transplant 1998 21: 487–495
Fritsch G, Witt V, Dubovsky J, Matthes S, Peters C, Buchinger P, Printz D, Handgretinger R, Lion T, Gadner H . Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation Cytometry 1999 1: 291–309
Landman-Parker J, Socie G, Petit T, Raynal B, Bourhis JH, Pico J, Brison O . Detection of recipient cells after non-T cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has different prognostic value Leukemia 1994 8: 1989–1994
Petit T, Raynal B, Socie G, Landman-Parker J, Bourhis JH, Gluckman E, Pico J, Brison O . Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T cell-depleted bone marrow transplantation Blood 1994 84: 3575–3583
van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Verweij PJ, Khan PM, Vossen JM . Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse Blood 1994 83: 3059–3067
Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, Niethammer D, Beck JF . Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center study of 12 children Leukemia 1999 13: 2079–2086
Lion T, Muller-Bérat N . Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations Leukemia 1999 13: 2059
This work was supported by a grant from the Austrian Research Foundation (P12856-Gen) to T Lion.
About this article
Cite this article
Lion, T., Daxberger, H., Dubovsky, J. et al. Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 15, 307–310 (2001). https://doi.org/10.1038/sj.leu.2402017
This article is cited by
Bone Marrow Transplantation (2022)
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats